These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 1667754

  • 1. Use of pentoxifylline as an inhibitor of free radical generation in peripheral vascular disease. Results of a double-blind placebo-controlled study.
    Ciuffetti G, Mercuri M, Ott C, Lombardini R, Paltriccia R, Lupattelli G, Santambrogio L, Mannarino E.
    Eur J Clin Pharmacol; 1991; 41(6):511-5. PubMed ID: 1667754
    [Abstract] [Full Text] [Related]

  • 2. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G, Sokola E, Lombardini R, Pasqualini L, Pirro M, Mannarino E.
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reactive oxygen metabolites in peripheral arterial occlusive disease.
    Ciuffetti G, Mannarino E, Mercuri M, Pasqualini L, Lombardini R, Ott C, Lupattelli G, Paltriccia R.
    Vasa; 1990 Sep; 19(3):234-6. PubMed ID: 2238818
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
    Kiesewetter H, Blume J, Jung F, Gerhards M, Leipnitz G.
    Dtsch Med Wochenschr; 1987 May 29; 112(22):873-8. PubMed ID: 3556133
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intravenous treatment of chronic peripheral occlusive arterial disease: a double-blind, placebo-controlled, randomized, multicenter trial of pentoxifylline.
    Rudofsky G, Haussler KF, Künkel HP, Schneider-May H, Spengel F, Symann O, Werner HJ.
    Angiology; 1989 Jul 29; 40(7):639-49. PubMed ID: 2662830
    [Abstract] [Full Text] [Related]

  • 12. The effect of pentoxifylline on retinal capillary blood flow velocity and whole blood viscosity.
    Sonkin PL, Sinclair SH, Hatchell DL.
    Am J Ophthalmol; 1993 Jun 15; 115(6):775-80. PubMed ID: 8506913
    [Abstract] [Full Text] [Related]

  • 13. Does pentoxifylline prolong the walking distance in exercised claudicants? A placebo-controlled double-blind trial.
    Ernst E, Kollár L, Resch KL.
    Angiology; 1992 Feb 15; 43(2):121-5. PubMed ID: 1536472
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of pentoxifylline on liver plasma flow in normal man.
    Suren A, Bauer FE, Rosenkranz B, Bircher J.
    Eur J Clin Pharmacol; 1991 Feb 15; 41(3):233-7. PubMed ID: 1748139
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of pentoxifylline and alprostadil on ocular hemodynamics in healthy humans.
    Dorner GT, Zawinka C, Resch H, Wolzt M, Schmetterer L, Garhofer G.
    Invest Ophthalmol Vis Sci; 2007 Feb 15; 48(2):815-9. PubMed ID: 17251482
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of glutathione infusion on leg arterial circulation, cutaneous microcirculation, and pain-free walking distance in patients with peripheral obstructive arterial disease: a randomized, double-blind, placebo-controlled trial.
    Arosio E, De Marchi S, Zannoni M, Prior M, Lechi A.
    Mayo Clin Proc; 2002 Aug 15; 77(8):754-9. PubMed ID: 12173710
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.